Female pattern hair loss, explained

Hair thinning is often discussed as though it only happens to men, but it's just as real, and just as common, in women. It tends to look different, though, which means the assumptions people bring to it, based on what male pattern baldness looks like, often don't quite fit. That mismatch is part of why female pattern hair loss can go unrecognized or unaddressed longer than it needs to.

This is patient education, not medical advice. Only an independent licensed medical professional can evaluate your specific pattern of hair thinning and determine whether any treatment is appropriate for you.

What female pattern hair loss is and how it differs from male pattern hair loss

Female pattern hair loss, sometimes called androgenetic alopecia in women, is the most common cause of hair thinning in women. Mayo Clinic describes it as a gradual thinning process tied to genetics and age-related hormonal changes, distinct from sudden or patchy hair loss caused by other conditions.

The pattern itself is the clearest way to tell it apart from male pattern hair loss. In women, thinning tends to be diffuse across the top and crown of the scalp, with the center part gradually widening over time. The frontal hairline is usually preserved, which is a meaningful contrast to male pattern hair loss, where a receding hairline and thinning at the temples and crown are typical and can progress to more complete baldness in those areas. Clinicians sometimes use a staging system called the Ludwig scale to describe how far the widening and thinning has progressed in women, separate from the Norwood scale used for men.

Female pattern hair loss becomes more common with age, and many women first notice it around or after menopause, though it can begin earlier. It's a chronic, typically slow-moving process rather than something that appears overnight, which is one reason it can be mistaken, at first, for normal shedding.

Common causes and risk factors

Genetics play a central role. A family history of hair thinning, on either side of the family, raises the likelihood of developing the pattern yourself, and hair follicles that are genetically more sensitive to circulating hormones tend to gradually produce thinner, shorter hairs over successive growth cycles.

Hormonal changes are the other major piece, which is why the menopause transition is such a common time for female pattern hair loss to become noticeable. Shifting hormone levels during this period can unmask or accelerate a genetic tendency that was previously subtle. Conditions that affect hormone balance more broadly, such as polycystic ovary syndrome, are also associated with androgenetic hair thinning in some women.

It's worth being clear that several other conditions can either contribute to hair thinning or closely resemble female pattern hair loss on the surface, which is exactly why a proper evaluation matters rather than assuming the cause. Thyroid dysfunction, whether the thyroid is underactive or overactive, is a well-recognized contributor to diffuse hair thinning. Iron deficiency, even without full-blown anemia, has also been linked to hair shedding in women. Certain medications, significant physical stress such as illness, surgery, or rapid weight change, and postpartum hormonal shifts can trigger a temporary shedding pattern called telogen effluvium, which looks different under the surface from androgenetic hair loss and often improves once the underlying trigger resolves.

Because several of these causes overlap in how they present, and because more than one can be at play at the same time, self-diagnosis from symptoms alone is unreliable. That overlap is the main reason a clinician's evaluation, rather than a home comparison to pictures online, is the appropriate starting point.

How female pattern hair loss is diagnosed

An evaluation typically starts with a detailed history: when thinning was first noticed, how it has progressed, family history of hair loss, menstrual and reproductive history, medications, and any recent illness, stress, or major life changes. A clinician will also examine the scalp directly, looking at the distribution of thinning, the width of the part, and the condition of the hairline and hair shafts.

Because thyroid dysfunction and iron deficiency can cause or worsen hair thinning, and both are treatable in their own right, clinicians commonly recommend basic blood work as part of the workup, checking thyroid function and iron studies such as ferritin. Depending on other symptoms, hormone levels may also be checked, particularly if there are signs suggestive of polycystic ovary syndrome or another hormonal condition.

In some cases, especially when the pattern is unusual or doesn't respond as expected to initial treatment, a dermatologist may recommend a scalp biopsy to look more closely at the hair follicles and confirm the diagnosis. This step isn't needed for every case, but it's a useful tool when the picture isn't clear from history and examination alone.

Treatment options and what the evidence shows

Topical minoxidil is the treatment most directly backed by FDA approval for this specific use: it is FDA-approved for treating female pattern hair loss, available over the counter in 2% and 5% strength formulations applied directly to the scalp. It's generally considered the first option clinicians discuss, in part because of that regulatory backing and its long track record of use in women.

Other options exist, but they sit on different regulatory footing. Oral minoxidil, taken as a low-dose tablet, is used off-label for hair loss in women, meaning a clinician is prescribing an FDA-approved medication for a use outside its specifically approved indication, which requires closer oversight of blood pressure and other systemic effects. Anti-androgen medications such as spironolactone are also sometimes discussed off-label for female pattern hair loss, based on the role hormone sensitivity plays in the condition, though this use requires clinician judgment and monitoring rather than self-directed use.

Whichever option is discussed, the same honest framing applies across all of them: results vary from person to person, changes take months of consistent use to become noticeable, and stopping treatment tends to reverse any gains over time because the underlying tendency toward thinning hasn't been removed, only counterbalanced for as long as treatment continues. No responsible clinician promises a specific outcome, and claims that guarantee dramatic regrowth are a signal to be cautious, not a sign of a legitimate service.

Addressing an underlying contributor, such as correcting an iron deficiency or treating a thyroid condition, is also part of treatment when one of those is identified, sometimes alongside a hair-loss-specific option and sometimes on its own.

When to see a clinician

It's reasonable to seek an evaluation as soon as a widening part, increased shedding, or visible thinning becomes noticeable, rather than waiting to see if it resolves on its own. Earlier evaluation gives a clinician more to work with and rules out treatable underlying causes sooner, even though it doesn't guarantee a particular result.

Certain accompanying symptoms are worth mentioning specifically when you talk to a clinician, since they can point toward an underlying cause beyond genetics: fatigue, unexplained weight changes, irregular menstrual cycles, or noticeable changes to skin and nails alongside the hair thinning. None of these confirm a diagnosis on their own, but they're useful information for a clinician putting the full picture together.

You can learn more about the biology behind pattern hair loss in our explainer on male pattern hair loss, and read about the two forms of minoxidil in topical vs oral minoxidil. Our what to expect in the first six months of hair treatment explainer covers a realistic treatment timeline, and you can browse more explainers in our Better Hair category. Read about our editorial standards on the About the Journal page.

The bottom line

Female pattern hair loss causes gradual, diffuse thinning across the crown and a widening center part, usually with the frontal hairline preserved, which sets it apart from the receding-hairline pattern more typical in men. Genetics and hormonal changes, especially around menopause, are the main drivers, but thyroid dysfunction, iron deficiency, and other conditions can contribute or closely mimic the pattern, which is why an evaluation matters before assuming the cause. Topical minoxidil is the only medication FDA-approved specifically for this use, though other options are sometimes discussed off-label under clinician supervision. Which approach, if any, makes sense for you is a decision made individually with a licensed clinician after a proper evaluation.

Frequently asked questions